Clinical Trials Directory

Trials / Unknown

UnknownNCT02880800

Does IVPCA Increase Opioid Consumption and Side Effects in Fast Track Orthopedic Procedures?

Does the Use of Intravenous Patient Controlled Analgesia (IVPCA) Increase Opioid Consumption and Side Effects in Fast Track Orthopedic Procedures?

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Mount Sinai Hospital, Canada · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The study aims to compare the use of intravenous patient controlled analgesia (IVPCA) versus the delivery of pain relief (per oral and intravenous (IV) medications as rescues analgesia) on an as needed basis within a well defined fast track protocol that includes multimodal analgesia for patients who are undergoing elective primary knee replacement surgery. The investigators assumed that with the multimodal analgesia regimen without the use of IVPCA will demonstrate decreased consumption of postoperative opioids, reduced incidence of opioids related side effects and decreased length of stay in the hospital.

Conditions

Interventions

TypeNameDescription
DRUGMorphine as IVPCAMorphine as IVPCA: Patients will be given a patient controlled analgesia (PCA) pump containing a standard solution of morphine as below: Morphine bolus 1mg with a lockout interval of 5 minutes, no background infusion and maximum 30 mg in 4 hours
DRUGHydromorphone as IVPCAHydromorphone as IVPCA: Patients will be given a patient controlled analgesia (PCA) pump containing a standard solution of Hydromorphone as below: Hydromorphone bolus 0.2 mg with a lockout interval of 5 minutes and a maximum dose of 6 mg in 4 hours.
DRUGMorphineIV opioids: Morphine 2 to 5 mg every 1h PRN (max. 20 mg/4h)
DRUGHydromorphoneHydromorphone 0.5 - 1 mg every 1h PRN (max. 4 mg/4h)

Timeline

Start date
2016-08-01
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2016-08-26
Last updated
2016-08-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02880800. Inclusion in this directory is not an endorsement.